Neobe Therapeutics
PrivateLast Round
Seed
Feb 29, 2024
Total Funding Raised
$2.97M
Momentum Score
25 /100
Company Overview
Neobe Therapeutics is a biotechnology company developing a synthetic biology platform to engineer programmable bacteria that remodel the microenvironment of solid tumors to improve immunotherapy efficacy.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine, Clinical Trials
Business Model
B2B
Customer Profile
Government Contracts, Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Neobe Therapeutics Comps
Public and private peers based on sector, stage, and business model.
Neobe Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Feb 29, 2024 | ||||
| Pre Seed | Nov 23, 2022 |
Neobe Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Deep Science Ventures | Seed |
| Pioneer Group | Seed |
| 2048 Ventures | Seed |
| Cancer Research Horizons | Seed |
| Discovery Park Ventures | Seed, Pre Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 24, 2026
Monthly visitors increased 51% MoM.
Neobe Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Neobe Therapeutics's valuation, stock price, and market status.
